These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 16461051

  • 1. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R, Herron AR, Lowry AS, Stroud RE, Stroud MR, Wharton JM, Ikonomidis JS, Crumbley AJ, Spinale FG, Gold MR.
    Am J Cardiol; 2006 Feb 15; 97(4):532-7. PubMed ID: 16461051
    [Abstract] [Full Text] [Related]

  • 2. Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation.
    Xu J, Cui G, Esmailian F, Plunkett M, Marelli D, Ardehali A, Odim J, Laks H, Sen L.
    Circulation; 2004 Jan 27; 109(3):363-8. PubMed ID: 14732752
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W, Willems R, Roskams T, Sergeant P, Herijgers P, Holemans P, Ector H, Heidbüchel H.
    Cardiovasc Res; 2005 Sep 01; 67(4):655-66. PubMed ID: 15913581
    [Abstract] [Full Text] [Related]

  • 4. [Involvement of matrix metalloproteinases in the regulation of myocardial extracellular matrix in patients with congestive heart failure].
    Yang YJ, Zhang X, Zhu WL, Huang Y.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1693-6. PubMed ID: 16854324
    [Abstract] [Full Text] [Related]

  • 5. Decreased plasminogen activator inhibitor and tissue metalloproteinase inhibitor expression may promote increased metalloproteinase activity with increasing duration of human atrial fibrillation.
    Gramley F, Lorenzen J, Plisiene J, Rakauskas M, Benetis R, Schmid M, Autschbach R, Knackstedt C, Schimpf T, Mischke K, Gressner A, Hanrath P, Kelm M, Schauerte P.
    J Cardiovasc Electrophysiol; 2007 Sep 27; 18(10):1076-82. PubMed ID: 17655664
    [Abstract] [Full Text] [Related]

  • 6. [Clinical on molecular basis of atrial fibrosis in patients with atrial fibrillation investigation].
    Ke D, Xu CX, Lin YZ, Zhang JC, Chen L, Lin LF, Hu XZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May 27; 33(5):459-63. PubMed ID: 15932710
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL, Huang SK, Lin JL, Lai LP, Lai SC, Liu CW, Chen WC, Wen CH, Lin CS.
    J Mol Cell Cardiol; 2008 Dec 27; 45(6):742-53. PubMed ID: 18692064
    [Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure.
    Moe GW, Laurent G, Doumanovskaia L, Konig A, Hu X, Dorian P.
    J Card Fail; 2008 Nov 27; 14(9):768-76. PubMed ID: 18995182
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation.
    Nakano Y, Niida S, Dote K, Takenaka S, Hirao H, Miura F, Ishida M, Shingu T, Sueda T, Yoshizumi M, Chayama K.
    J Am Coll Cardiol; 2004 Mar 03; 43(5):818-25. PubMed ID: 14998623
    [Abstract] [Full Text] [Related]

  • 10. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP, Huang CY, Wang JS, Sun PC, Shih CC.
    Ann Thorac Surg; 2008 Oct 03; 86(4):1243-9. PubMed ID: 18805169
    [Abstract] [Full Text] [Related]

  • 11. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
    Wang W, Zhang HT, Yang XL.
    J Cardiovasc Med (Hagerstown); 2013 Apr 03; 14(4):265-9. PubMed ID: 22929563
    [Abstract] [Full Text] [Related]

  • 12. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.
    Wilson EM, Gunasinghe HR, Coker ML, Sprunger P, Lee-Jackson D, Bozkurt B, Deswal A, Mann DL, Spinale FG.
    J Card Fail; 2002 Dec 03; 8(6):390-8. PubMed ID: 12528092
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
    Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH, McClure CD, Spinale FG, Zile MR.
    Circulation; 2006 May 02; 113(17):2089-96. PubMed ID: 16636176
    [Abstract] [Full Text] [Related]

  • 14. [Changes in gelatinases expression and activity in human atria during atrial fibrillation].
    Ke D, Xu CX, Zhang JC, Chen L, Lin YZ, Lin LF, Hu XZ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb 02; 33(2):137-42. PubMed ID: 15924808
    [Abstract] [Full Text] [Related]

  • 15. [Role of matrix metalloproteinase and tissue inhibitor of metalloproteinase in atrial structural remodeling in patients with atrial fibrillation].
    Wang W, Wu PS, Yang XL.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 May 02; 30(5):1160-2. PubMed ID: 20501421
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression.
    Polyakova V, Hein S, Kostin S, Ziegelhoeffer T, Schaper J.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1609-18. PubMed ID: 15489093
    [Abstract] [Full Text] [Related]

  • 17. Extracellular degradative pathways in myocardial remodeling and progression to heart failure.
    Spinale FG, Gunasinghe H, Sprunger PD, Baskin JM, Bradham WC.
    J Card Fail; 2002 Dec 19; 8(6 Suppl):S332-8. PubMed ID: 12555141
    [Abstract] [Full Text] [Related]

  • 18. Novel approaches to retard ventricular remodeling in heart failure.
    Spinale FG.
    Eur J Heart Fail; 1999 Mar 19; 1(1):17-23. PubMed ID: 10937974
    [Abstract] [Full Text] [Related]

  • 19. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
    Zhu H, Zhang W, Guo CH, Zhang G, Zhang WD, Zhong M, Yang GR, Ge ZM, Zhang Y.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):45-8. PubMed ID: 15808077
    [Abstract] [Full Text] [Related]

  • 20. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW, Verma S, Weisel RD, Li RK.
    Cardiovasc Pathol; 2005 Jan 05; 14(2):49-60. PubMed ID: 15780796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.